Gösta Dahlén
- Surgery top 2%
- Endocrinology, Diabetes and Metabolism top 1%
- Cardiology and Cardiovascular Medicine top 2%
- Cancer Research top 2%
- Epidemiology top 5%
- Co-authors
- Kåre BergMargareta BlombäckU de FaireChristian LandouAnders HamstenBjörn WimanGöran WalldiusAlfred Szamosi
- Topics
- Lipoproteins and Cardiovascular Health (17 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers)Cancer, Lipids, and Metabolism (5 papers)
- Journals
- New England Journal of MedicineThe LancetThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- SwedenNorwayUnited States
In The Last Decade
Gösta Dahlén
31 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Surgery 1.3k
- Endocrinology, Diabetes and Metabolism 960
- Cardiology and Cardiovascular Medicine 852
- Cancer Research 766
- Epidemiology 538
Countries citing papers authored by Gösta Dahlén
This map shows the geographic impact of Gösta Dahlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gösta Dahlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gösta Dahlén more than expected).
Fields of papers citing papers by Gösta Dahlén
This network shows the impact of papers produced by Gösta Dahlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gösta Dahlén. The network helps show where Gösta Dahlén may publish in the future.
Co-authorship network of co-authors of Gösta Dahlén
This figure shows the co-authorship network connecting the top 25 collaborators of Gösta Dahlén. A scholar is included among the top collaborators of Gösta Dahlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gösta Dahlén. Gösta Dahlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 19 | |
| 3 | 35 | |
| 4 | 17 | |
| 5 | 121 | |
| 6 | 18 | |
| 7 | 47 | |
| 8 | 21 | |
| 9 | 98 | |
| 10 | 23 | |
| 11 | 15 | |
| 12 | 187 | |
| 13 | 25 | |
| 14 | 374 | |
| 15 | 11 | |
| 16 | 15 | |
| 17 | 14 | |
| 18 | PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONbreakdown → | 1287 |
| 19 | 261 | |
| 20 | 11 |
About Gösta Dahlén
Gösta Dahlén is a scholar working on Immunology and Allergy, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 31 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (960 citations), Cancer Research (766 citations) and Hematology (532 citations). Gösta Dahlén has collaborated with scholars based in Sweden, Norway and United States. Frequent co-authors include Kåre Berg, Margareta Blombäck, U de Faire, Christian Landou, Anders Hamsten, Björn Wiman, Göran Walldius, Alfred Szamosi, Anne‐Lise Børresen and Mats Frick. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.